« June 2008 | Main | August 2008 »

July 2008

July 31, 2008

Olympus BLISS HD™ Virtual Microscopy System Offers Superior Optical Performance, Push-Button Ease

CENTER VALLEY, Pa., July 29, 2008 – Olympus, a major provider of virtual microscopy solutions worldwide, offers a completely new look at the field with its high definition virtual microscopy system, the BLISS HD™. A comprehensive workstation incorporating a dedicated microscope stand, scanning instrumentation and powerful, easy-to-use software, the system offers the highest optical performance commercially available for virtual slide scanning.

Blisshd

BLISS HD is ideal for training, education, consultation, testing, archiving, research and other purposes. It offers a high degree of flexibility, allowing multiple-magnification scanning as well as an option for high-resolution oil immersion scans. Its Virtual Z™ feature allows capture and display of multiple Z focal planes for true virtual microscopy applications, and the system is designed to be easy to use, with simple one- or two-touch operation.

“BLISS HD is for clinical or research applications where having the best image quality possible, along with the greatest ease of operation, is desirable – areas like teaching, consulting, archiving and publishing,” said Christopher Higgins, Group Manager, Clinical Digital Imaging Marketing for Olympus America. “All of the vitally important slide data is captured for future reference, and because nothing is lost, these slides will work effectively for tomorrow’s most demanding virtual microscopy applications.”

The BLISS HD system includes a dedicated microscope stand optimized for virtual slide applications with very fast Z-axis response times, a motorized six-place nosepiece, a high-resolution three-CCD digital camera, and powerful, easy-to-use acquisition and control software running on the Windows Vista™ operating system. The BLISS HD workstation also includes SlideTray™, a digital slide organizer, WebSlide® Enterprise Viewer and Database software, storage for 750-1000 slides and dual 20-inch color monitors. The system comes equipped with Olympus 1.25x, 10x, 20x and 40x UIS2 plan apochromatic objectives. The optional oil scanning package includes a 60x, 1.35 NA, UIS2 objective plus software.

For more information on the Olympus BLISS HD virtual microscopy slide scanning system, contact Olympus America Inc., 3500 Corporate Parkway, Center Valley PA 18034-0610; phone 1-800-455-8236; visit www.olympusamerica.com/blisshd, or email microscopes@olympus.com.

About Olympus Scientific Equipment Group
Olympus America Scientific Equipment Group provides innovative microscope imaging solutions for researchers, doctors, clinicians and educators. Olympus microscope systems offer unsurpassed optics, superior construction and system versatility to meet the ever-changing needs of microscopists, paving the way for future advances in life science.

About Olympus
Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products. Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

* Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
* Advanced clinical and research microscopes;
* Lab automation systems, chemistry-immuno and blood bank analyzers and reagents;
* Digital cameras and voice recorders.

Olympus serves healthcare and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes. For more information, visit www.olympusamerica.com.

Electronic Visualization Laboratory to Build a Multi-Sensory Touch Tabletop for 2D/3D Data

The National Science Foundation (NSF) recently awarded a Major Research Instrumentation grant in the amount of $450,000 to University of Illinois at Chicago’s Electronic Visualization Laboratory (EVL) to build OmegaTable, a modular multi-sensory touch tabletop for interactive 2D and 3D visual data exploration.

This powerful virtual-reality device will enable scientific communities to view, share and interact with large-scale 2D and 3D data at the same time, and will enable computer scientists to study the integration of multi-sensory touch and gestural interaction techniques for seamlessly manipulating both 2D and 3D data.

“Integrated visualization instruments with powerful computing capabilities are becoming important in domain science because scientists have access to more and more types of electronic data,” says EVL director Jason Leigh. “These displays are the new microscopes and telescopes, enabling researchers to zoom-in on interesting phenomena in today’s digital world.”
 
The resolution of OmegaTable will be at least 24 million pixels, and will have the ability to display 2D and autostereoscopic 3D simultaneously. By incorporating gestural interaction, the OmegaTable will allow users to experience virtual reality without being encumbered with special glasses, hand-held controls, or gloves.
 
Eight leading domain-science research and education institutions have already expressed interest in testing and adopting OmegaTable, including the Science Museum of Minnesota, the National Center for Microscopy and Imaging Research at the University of California, San Diego, and the Pacific Rim Applications and Grid Middleware Assembly, to facilitate large-scale collaborations requiring advanced cyberinfrastructure.

“We’re pleased to have this critical NSF funding to construct this next generation device, and a scientific community eager to work with us,” says Leigh. “As is the goal of all of our visualization display technologies, we expect that the OmegaTable will transform science team workflows by providing new and more intuitive ways of seeing and interacting with information.”

July 30, 2008

Digital diagnosis: Consultations get tech-savvy to save patients time

sun-sentinel.com/business/sfl-flrxedocs0721sbjul21,0,4334782.story

South Florida Sun-Sentinel.com

More patients are taking advantage of e-mail consults

BY BOB LaMENDOLA

South Florida Sun-Sentinel

July 21, 2008

Mike Holland came home from a business trip a few weeks ago in so much pain he tried something new: He made a doctor's appointment online. The next morning, he arrived and saw the doctor in minutes.

A week later, on the road, his new medicine made him sick. The Hollywood computer consultant logged onto the same physician consulting Web site and filled out a form detailing the problem. Hours later, he had e-mail advice from his internist, Dr. Rene Reyes.

Another electronic medical checkup completed. The small and slow-growing trend of doctor e-consults got a little bigger.

"I figured I would never even hear back from them," said Holland, 53. "Getting specific advice about the medication I was taking and the treatment I was getting was tremendous. Not having to wait a week for an appointment and not having to sit for two hours in the waiting room, that was really something."

After more than four years in the mainstream in Florida and a few states, online doctor consultations are catching on, although not like many had hoped. Only a fraction of doctors offer the service, and a small number of their patients take advantage.

Practice on the rise
Proponents of e-consults said the number has jumped since Aetna, Cigna and other insurers began paying for them nationwide in January. They predict the practice will one day become a prime option for patients dealing with simple health issues.

"It's really convenient for the patients and great for the doctors, too," said Dr. Maureen Whelihan, a West Palm Beach obstetrician who has consulted online for 15 months.

Blue Cross Blue Shield of Florida began offering online physician contacts in 2004 as a way to improve patient satisfaction, ease office burdens on doctors and save a little money, said Lynn Monson, the insurer's director of health information technology.

A few thousand of the insurer's 28,000 doctors belong to the various online systems, and the number is growing. From all those Florida doctors, Blue Cross pays for a dozen e-consults per month on average, although many more may be using the system for free contacts, Monson said.

"I would love to see it take off like hotcakes, but it hasn't," Monson said. "It's something that's going to come of age."

Popular with patients
Surveys show patients like the idea of contacting doctors by e-mail. But in California, only 4 percent of people reported doing so last year.

"The reality is that most patients unfortunately are not tuning in yet," said Dr. Nigel Spier, a Hollywood OB/GYN who answers patient e-mails daily and late at night. "Younger patients are catching on. But certainly the reflex is that if people have a question, they pick up the phone, they don't go to their computer."

To contact a doctor online, patients go to a password-protected Web site to find forms requesting lab results, prescription refills, appointments and office matters. Typically these are free and fielded by the office staff.

To initiate an e-consult about medical issues, patients answer a series of questions about their illness and medical history. The system often asks different questions depending on the patient's answers, as a doctor would. The doctor gets notified of the inquiry and posts an answer online for the patient to look up.

"When they fill out the form, all the questions I would have asked [in person] are already answered," Whelihan said. "I can actually make a pretty good diagnosis."

E-consults cost $25 to $40, payable by credit card. If insurance covers it, the patient may only face a small co-pay.

"Once [patients] use it once or twice and realize how nice it is, they use it more and more," said Reyes, who started e-consults in April.

Not everyone's sold
Some doctors and medical organizations are skeptical of e-consults, saying an online exchange cannot replace a face-to-face visit and increases the risk of a doctor misdiagnosing a serious problem.

"There's so much potential for miscommunication when you can't see someone's face or detect the tone of their words, or watch their body language," said Dr. David Hutchinson, president of the Minnesota Academy of Family Physicians.

Proponents of cyber-medicine dismiss such fears, saying doctors can use their judgment to restrict e-consults to simple health issues.

Reyes' hand-held wireless unit jangled with an online question from a man whose ulcer resumed bleeding one night. He said he quickly called and ordered him to the emergency room.

RelayHealth, a leading online consultation system, says about one-third of its e-consults end with the doctor asking to see the patient in person.

Doctors who like the approach tend to be younger and tech-savvy. They find that dealing online with routine illnesses and matters is faster and more efficient than taking phone calls, and produces better records.

The online systems also ease foot traffic at a time when office visits have surged by 20 percent in five years, federal figures show.

Coverage concerns
The fact that big insurers have started covering e-consults bodes well for growth, supporters say. Cigna and Aetna tested e-consults since 2006 in Florida and other states before going national. Insurance officials said the service fits the trend of having patients take more responsibility for their health and costs.

The number of Cigna doctors using the system jumped by one-third this year, spokesman Joe Mondy said, but still has reached only 12,000 of 500,000. At Aetna, not 5 percent of 490,000 doctors are signed up, spokesman Walt Cherniak said. Doctors may hold off unless many patients show interest, while patients may not even know their doctor has access.

RelayHealth, a California e-consult firm, has signed up 17,000 doctors since 1999, said Ken Tarkoff, vice president and general manager. Thousands more use Medem Inc., Medfusion and others.

One in 10 of Spier's 5,000 patients have signed up for his service. One in five of Whelihan's 5,000 patients have; she fields one e-consult daily.

"A lot of physicians say, 'You're so out there.' We're really not," Reyes said. "This is 2008, folks. This is a natural evolution."

Bob LaMendola can be reached at blamendola@sun-sentinel.com or 954-356-4526 or 561-243-6600, ext. 4526.

How best to use online consultations, or e-visits, with your physician:
Use e-consults with doctors with whom you already have a relationship and for minor health issues. That includes colds, follow-up questions after an office visit, routine infections, aches and monitoring an ongoing illnesses.

Do not consult a doctor online about a new illness or about potentially serious issues such as bleeding, sharp pain, a change in pain, chest discomfort, traumatic injury, or multiple, complex symptoms.

Explain your medical issue on the Web site's forms as thoroughly as possible, in plain language, to avoid misunderstanding. Do not leave out or exaggerate any symptoms. Avoid humor that could create confusion.

Explain your medical history fully, including all medications and supplements you take.

Make sure the doctor's system is secured to protect your medical privacy.

Sources: American Academy of Family Physicians, RelayHealth, Medem, Medfusion

July 29, 2008

Digital Slides, DICOM and PACS

The Daily Scan has an interesting post defining the terminology and issues associated with digital slides, DICOM and PACS

July 28, 2008

A Quality Pathology Report, Voice in the Wilderness

What does the social networking MD network, Sermo, think about image enhanced reports, telepathology, externalizing pathology images, etc...?

This was a post on Sermo several months ago.  I thought of it recently when our group was asked to upload images into the hospital PACS for viewing by clinicians.  This would include both gross and microscopic images.  The institution provided excellent support in terms of software, upload application, training and documentation tools without a requirement to do so.  It can be done ad hoc as individual pathologists see fit for particular cases. 

For several years with different LIS and PACS systems I have made this part of my practice.  I found it useful for documentation, substantiating diagnosis, providing education to clincians and since patients may and do see their pathology reports, illustrations that may be informative if they can be explained or legends are complete.  Examples of the latter include illustrating mitoses or margins for documentating grading and staging when discussion with oncologist takes place. 

The problems, questions and concerns associated with this are numerous: what fields to select, what magnification, how many, value added, legal culpability if some action is or is not taken based on  image(s) rather than text diagnosis, cost, time and reimbursement.  Most of my colleagues always question the value added and how much effort it will add to their workload for what gain to their practice, division, department or institution.  Some get concerned that clinicians will copy images of the PACS to be used in papers and publications without due credit.  I have been doing this for years with radiology images and I have never had a radiologist mention a word.  I have even inquired if they would like to contribute and they inevitably refer me to the report and images on the PACS.  And what is the value added of uploading images of a basal cell carcinoma for a clinically suspected one or a benign diagnosis that is compatible with the clinical picture of a dermatology lesion.  I select dermatopathology cases because they seem to have the most say among clinicians whether they need it, want it, would use it, value added, legal implications since pathology is on the dermatology boards, etc..., much like discussions that take place for adding microscopic descriptions.  Can clinicians make out the microscopic description?  It is part of some if not all pathology reports depending on practice and the pathologists.  No doubt anatomic pathologists, like all specialties, like all fields, have their own personalities, concerns and "best practices".  This varies widely among anatomic pathology just in terms of number of blocks submitted, number of levels, special stains used, immunohistochemistry panels/reagents/kits, etc... and how those pathologists and practices work with clincians that utilize their services.  No 2 are alike. 

I think this post hits on this and discusses the issues amongst pathologists and clincians.  I scrubbed the Sermo IDs; most are pathologists, some are clinicians, I think you can tell which are which and get a sense of where Sermo pathologists responding to this think about these issues.

Would welcome your comments.

---------------------------------------------------------------------------------------------------------------------------

POSTING:

Here is what I believe is "quality pathology reporting"

1 . Micrsocroscopic description , describing salient features as to how the pathologist derived at the final diagnostic interpretation.

2 . Representative digital image(s) highlighting the salient features in the diagnosis , preferably a scanning or low power, if presentable, and/or at least an intermediate or high power view, demonstrating supportive architectural and cellular details ( this way other clinicians, GI/Derm, or pathologists may be able to review report).

3 . Availability of pathologist to show diagnostic images over the internet ( secured channel , no patient identifying information disclosed ), for immedate second opinion or review by other experts .

4 . Communication between clinician and pathologist with documentation of issues discussed on final report ( may be in a comment section ), i.e . the diagnosis of malignancy was discussed with the clinician at date and time, confirming the diagnostic impression.

We here use a high resolution digtal photomicroscope, which can easily be transferred online with still photograph or through screaming videography.

Our physicians here aprreciate this commitment to quality.  Would like to know your opinion in this regard.

**************************************************************************************************************************

COMMENTS:

I love it. Sounds exactly like what I'd prefer when reviewing a pathology report. (Especially the clinician-pathologist collaboration part)

I dont' think this is about small or large practices being eliminated, because the technology currently is affordable; if your kid can afford a cellphone to textmessage, and iphone, then your pathology department surely can afford technology that would contribute to high quality pathology practice; just my opinion

those excellent pathologists you speak of should not have a problem with others reviewing their reports. SHOW THE WORLD YOUR DIAGNOSES; DON'T HIDE THEM IN A FILE, LIKE WE HAVE DONE SINCE THE BEGINNING OF TIME, and require FEDEX and UPS to deliver slides for second opinion, of course this will still take place.

Showing the photos is a natural extension of this once the technology becomes good enough, I guess. Unlike radiology, though, what's in the photos is what we select, not the whole lesion (unless it's tiny). So there's still opportunity for bias, but it certainly would shine more sunlight on the case.

Here's a question that maybe the nonpathologists can weigh in on too -- I think with the advent of PACS on the wards, we all look at more radiology than we used to (and maybe catch things the radiologist misses from time to time). Would that happen with pathology, if microscopic images were available?

I doubt it. There isn't the exposure to path like there is for radiology.

I would love it, but the labs I've dealt with seem too busy cranking out the specimens to do this kind of in-depth interaction. Probably like everyone else, they have to run harder just to stay in place income-wise.

Some clinicians can read xray and CT images just as well as a radiologist; not the case for pathology; however, the idea here is referenced to evidence-based medicine with regards to putting a digital image on the report, that could at least reflect how the primary reviewing pathologist came up with the diagnosis as rendered; ie malignant ductal cells to call breast cancer in a pediatric patient, or bizarre lymphoid cells to call a high-grade lymphoma in a young teen; this way other reviewing pathologists be it for the patient or clinician can say, yea I can see how the diagnosis came to be rather than, TRUST ME I'M YOUR PATHOLOGIST. Well, as I have stated before, tell that to the mother of a teen fighting for her life because the pathologist called an immature, malignant teratoma, a DERMOID CYST, and delayed treatment for nearly six months.

What I usually get for a micro is "microscopic examination substantiates the above diagnosis." If I get a micro it is because the pathologist has no idea what he/she is looking at. If I had it my way I would get a copy of the slide with the report.

These seem like good ideas, but I think that the images that would be added to reports would be the same that are shown at Tumor Board. If the image is to be placed in the report, then it will end up in the patient record. This would be okay if the entire case could be placed there, but with only a solitary (or maybe 2) images to show the area representative of the diagnosis, there may not be all the factors present in the image that is in the microscopic description. The legal beagles would have ammunition then to ask where in the image is the stuff mentioned in the microscopic. The answer of 'it is only a representative image' while acceptable to us, would just give the impression of the microscopic being 'made up' in a courtroom with a good lawyer. (Not that our cases would end up being sued, but with the catchall lawsuits out there nowadays, everyone gets named and there is no reason to give ammunition to anyone.) IMHO

That has been the oldest argument,and it does not stand up, because the slides and blocks, according to CAP accreditation standards, will be maintained for review for an appropriate period of time. We are simply suggesting that representative images of the most salient diagnostic feature (not all diagnostic components) should be digitally placed on the report for electronic and permanent record filing. For instance, if you make a diagnosis of malignancy, which is a microscopic diagnosis, then show features of malignancy (i don't care about the final histological classification which can be confirmed on review of the entire slide for confirmation prior to treatment), you simply should not be able to justify a person's breast coming off with 'WORDS' only, and no other evidence-based source. Let's get modern; I am not affraid of the courts, when I use sound scientific based judgement to finalize my pathological diagnosis.

As per above, for instance with breast cancer, I include 1) picture of infiltrating malignant ducts, either in sheets, or degree of tubular formation; 2) higher power view of the nuclear morphology and, an example of mitosis; 3) the highest grade of DCIS, 4) angiolymphatic invasion and 5) lymph node status, with perinodal extension if present. A total of five pictures that generally take me 5 minutes to place on the report. I think this is representative of what the surgeon or oncologist needs to know to appropriately prognose and treat this patient.

we have a system in place that once you take the picture, the picture is automatically sent to the final pathology report and place in the appropriate position on the report.

It seems to me your immature teratoma example raises one problem that your system leaves unsolved (and no system other than peer review can solve satisfactorily). If the first pathologist only includes images of areas consistent with dermoid cyst and doesn't see, recognize or photograph the immature areas, then the images in the final report will be consistent with dermoid cyst, not immature teratoma. It's likely that a pathologist including images in her/his report will select those images from the fields s/he views as most diagnostic of her/his diagnosis.

Thus, images may help if the diagnosis is flat-out wrong/incomplete, but might not help in matters of grading, subclassifying, or finding malignant areas in a benign lesion. You only see what you see.

There are other clues in the final pathology report; like gross examination, and clinical correlation. First the gross showed a 14 cm necrotic tumor, and secondly there was a clinical suspicion that raised the possibility of malignant through xray studies, etc, that's why a frozen section was performed. But your premise is correct that it requires a complete team to assess accuracy in diagnostic reporting in any field be it pathology or radiology; that is why the clinicians have a certain duty or responsibility to challenge the pathological diagnosis when it does not correlate with the clinical impression.

I am of the mind that most of us medicine docts want the best for the patient; having said this, I don't think one, pathologist, would make up or cover up mistakes by putting normal or benign tissue on that which is obviously malignant; by the way the slide was not subtle with diagnostic features of malignancy; this was gross negligence. I want to emphasize to you in your youth, that we pathologists should never operate in a bubble.

Oh, by the way, if you know of incompetent pathologist that would do this, you can believe one thing, (s)he won't practice pathology for long; the clinical colleagues will assure this, if not the pathology community; it is a tough specialty to practice, reed, and mistakes are costly in this profession, so I hope you don't think it will be easy to make mistakes as you have aluded to above, without very serious consequence to your pathology career.

That's why in my previous comment, I advise you that when in doubt, rule IT out ; this means, when you are not sure, YOU BETTER ASK SOMEONE. Get a second opinion, or send it to an expert with a lot more experience on such pathology issues, i.e questionable whether or not IT IS MALIGNANT.

Always remember this, you can be wrong on benign lesions (SK, fibroadenoma, demoid cyst, etc), you may apppear as an unwise pathologist among our colleagues, but there is no harm done, because benign lesions DON'T KILL; however, if you are wrong about malignant diagnoses, either way, you are screwed; why? because malignancy don't go away, and eventually, if the patient is not treated and even sometimes if they are treated, malignancy WILL CAUSE DEATH TO THE PATIENT, (apart of the definition of malignant tumor)

This would be a welcome upgrade to my current service...very nice!

thanks; we just need to be persistent about bringing it into being; I think there is a push by the pathology community at large to at least include digital images on final pathology reports; hopefully, that would come to past, with eventually including a copy of the slide that would include representation of all diagnostic features to be sent to patient's clinical doctor along with the final report, if the clinician requests it at no fee to patient or doctor.

We need to be reminded that patients go all over the country for treatment, and so this would be important, in addition to monitoring quality for those who have exclusive contracts, and lack external peer review.

This kind of information sharing is one of the obvious benefits of EMR technology and where I hope we are all heading. The transition is difficult, but really quite exciting. Keep it up....I love to see this stuff!
 
How much do you think telepathology would aid in this process? I gather that images that are sent out for telepath consult would be included in the final report along with the statement about peer review (or 2nd opinion or whatever statement is used by your service). Does this sound feasable to you?

I think, albeit not accepted by the general community of pathologists, telepathology will become the standard way of doing pathology practice, particularly for very remote location, like Wyoming. Here is what I envision how telepathology consultation service could work: 1) The telepathology consultant (expert or second reviewer) is first notified by the original viewing pathologist, and a code, series of alphabet and numbers similar to a surgical pathology number (unique identifyer) is given to the consultant for future reference (i.e. slide or case identification number that also identifies the patient) which is shown to the consultant at the same time as the slide is being viewed by the consultant;2) the consultant could copy unique images from the slide, selecting representative unique diagnostic features, and adding text comments as to what was discussed and the final conclusion, ALL TO BE SAVED ON A ELECTRONIC DATABASE, at selected time interval or ad infinitum for future reference.

Example of above:
Code, unique identifying number: TP080001, identifiying the patient as "Suzie Que"
Original Pathologist: Contributor
Telepathology Consultant(s): Dr. Expert
Comment:
The features of the presented slide, as demonstrated by (selected images) are compatible with GIST; suggest correlation with CD117, ..... (other stains, or clinical studies).
Notice I included more than one(1) telepathologist/consultant for the reviewing pathologists

Before this discussion closes, I wanted to comment about a schemata as to how telepathology can be used:
Telepathology Consultant (usually affiliated with academic setting with cream of the crop, dermatopathologist, cytopathologist, hematopathologist etc.)<---------->image/videotography transferred through electronic, network database<------> field pathologist, solo or group (good generalist, good diagnostic skills, and know when to seek second opinion). Notice the double arrow to suggests reversible communication; analogous to a soldier out in the battle field calling on higher ranks/experience or expertise to give help or second opinion.

The clinicians we service wouldn't have clue as to what they were looking at if we provided a picture of the lesion on the report, and I don't believe they have any urge to learn a little microscopic pathology...that's our job. If you want to brighten up your report, then do it, but it all costs money if you print paper reports that would otherwise be produced in black and white. The images also clutter up the electronic world of data memory.

I wouldn't spend the time adding a picture(s) to the report, because our average clinician is in no position to judge my diagnosis. If I'm cited in a lawsuit, the plaintiff's counsel will have a pathologist review the glass slide (which is one reason why we keep them, folks); I wouldn't want to be cornered/limited by the photos I supplied by some sharp attorney.

I tend to focus much more on HOW the information is presented to the ordering clinician, with clear cut comments/recommendations. I've learned over the years what diagnoses will generate a phone call (and rightfully so); as such I try to clarify points of the diagnosis at the time the clinician reads the report. I tend to repeat key words like "benign" in the report, in order to avert a disaster of organ removal for a benign diagnosis that the surgeon has never heard of before. I'm probably the target of much snickering by the local docs behind closed doors for my apparent repetition, but I don't care. The studies that have come out in the pathology literature in the last few years clearly indicate that many clinicians are pretty poor at interpreting a pathology report...adding a nice color shot of the lesion I don't think will improve that.

No, but it looks cool!!!  And its better than nothing; other pathologists can review what you call cancer or not, that 's all for patient safety since patients are going all over the country for treatment, and not in little village AMERICA.; plus, electronic pathology reporting is going to replace your "black and white" printer or fax; doctors are on the go, and are not going to wait for a faxed report, when they can go to their internet site and pull off the patient report whereever they are, regardless if there is a digital image on there are not. Just my humble opinion.

I would ask how many pathologists would be willing to put their name on an "outside" case review report (as we call cases that are shipped in because the patient was diagnosed elsewhere but are recieiving treatment at our institution) based just on what was shown in a few digital pictures that were selected by the original pathology department? If the answer is no, then what is the point to add the pictures for other pathologists? Any case that will be reviewed had better be reviewed with ALL the available information (i.e., the whole set of slides), or the entire digitized slide sets (which is now possible due to the slide digitizers on the market). If nothing else, it allows the pathologist to verify the slide/case accession number prior to penning a new report. How would you verify that the picture(s) with a limited view of the slide(s) are what are really on that slide (i.e., no screw ups in plugging in the digital image into the wrong patient report)?

I am a dermatopathologist, and most of our dermatologists have specifically asked NOT to have a photomicrograph on the reports. Because dermatologists train in dermpath in their residency, they feel it holds them "liable" for the accuracy of the diagnosis.

For the dermatologist above who would like to get a slide with each report, we DO provide this service to many of our referring physicians (obviously for free). We cut an extra slide for each case and send it out to them. It is nice because if they call you to discuss a case, you can both look at a representative slide at the same time.

I would not have a problem putting my name on a consultation report based on telepathology images. The disclaimer would be included of course (The evaluation and findings noted are based on evaluation of representative digital images only. If there is concern for a more worrisome entity, slides will be required prior to further evaluation). Or something to that effect. It would not be alot different then when peer reviewing representative slides of a colon cancer. The key is to include the term representative (sections/slides/digital images/whole slide images). At least for me.

July 25, 2008

Will the iPhone Change Medicine Forever?

From The Dark Report:

"To find new uses for its iPhone, Apple recently conducted a clever competition to see who could develop the most impressive applications built with iPhone 2.0 software developer tools. Two of the top 10 applications were medical applications, and both of these applications were so impressive that it got this editor thinking that the iPhone could forever change medicine as we know it.

The first medical iPhone application came from Modality, Inc. Modality specializes in educational materials for the medical profession. What they unveiled was a 3-D program designed to replace flashcards typically used by medical school students to learn body parts. For example, the iPhone shows a graphic of a slice of the human brain. It allows the med student to see 10 push pins on different parts of the brain, click on each one, and attempt to correctly name each feature. If the answer is wrong, the correct answer is displayed so the med student can learn from that mistake. A medical school student using this software on his iPhone approached one of the doctors involved in its development and said “I learned 10 new anatomical terms today while waiting for the bus.” The portability of the software from Modality on the iPhone, coupled with its extensive knowledge base, is sure to appeal to medical school students.

Pathologists will find the second medical iPhone application unveiled by Apple to be even more amazing. MIMvista, a small software company out of Cleveland, Ohio, unveiled an application that allows radiologists to have charts, MRI results, and more sent right to their iPhones. The radiologists can adjust contrast to see problem areas in scans better. They can pan in or out. They can even draw lines directly on the images on their iPhones during in-person meetings with patients and their families to illustrate items in the images. “Doctors will be able to access this information on the golf course, share it with each other to get second opinions, and show patients and their families first-hand, in color, and in 3-dimensions,” said one of the developers responsible for the product."

July 24, 2008

Olympus Introduces the New dotSlide 2.0 Virtual Microscopy System

Olympus has launched the new version of its range of dotSlide digital virtual microscopy systems. dotSlide 2.0 offers enhanced functionality and image quality for scanning entire slides at high resolution and fidelity, making them accessible and fully navigable, anywhere on the globe.

The three available models (dotSlide MD, manual version; dotSlide SL, fully automated version with slide loader; and dotSlide TMA, with tissue microarray module) now offer more innovative features to enable users to examine virtual slides without being near a microscope, faster and even easier than before.

Furthermore, Net Image Server (NIS) SQL expands the dotSlide family with a more flexible and powerful Client Server Database for the management of images and data. The unique dotSlide 2.0 is the perfect system for providing high-throughput and high-content capabilities for all pathology and research applications.

The Olympus dotSlide workstation and server system are equipped for optimal speed, precision, security and performance and enable fully controllable remote access, whatever the requirements. Data and associated meta-data are saved in a bespoke data management system meaning that slides can be scanned in one location and reviewed almost instantaneously in another, by users anywhere on the globe via a web browser.

The dotSlide system features a robotic arm that places the slides onto the stage holder and an integrated barcode scanner that ensures that any bar-coded meta-data are automatically loaded and linked with the resultant virtual image. Furthermore, all dotSlide models use the advanced Olympus BX51 microscope, which offers extraordinary optical performance.

As well as being fluorescent-compatible, the standard dotSlide MD system allows slides and meta-data are loaded manually and the virtual file created automatically based on the user´s preferences. With dotSlide SL, slides are automatically loaded from the slide loader, which holds up to 50 slides in 5 trays. The dotSlide TMA is now a complete system incorporating a tissue microarray (TMA) module with the new client server database Net Image Server (NIS) SQL. This combination facilitates the acquisition of small tissue cores as single images, which are then immediately uploaded together with the relevant metadata and overview of the TMA slide to the NIS SQL database for traceability. This allows users to perform effortless analysis of the TMA and metadata and permits a single core from the overview TMA slide image to be selected visually.

The new Olympus dotSlide 2.0 offers additional innovative functions and is even easier to use than before, providing users with superior functionality, usability and performance. The user is now guided through the virtual slide acquisition process step-by-step by an intuitive Scan Wizard. This graphical user interface (GUI) features large control icons and allows even inexperienced users to immediately produce the perfect image results they require in just a few steps with minimal training.

dotSlide 2.0 is now capable of scanning multiple large specimens in up to 15 Z-planes. Virtual Z allows the reviewer to simply focus through the specimen, as well as examining regions of interest in different dimensions. This enables better observation for remote consults, as well as consistent training for students and pathologists. The dotSlide autofocus function offers improved autofocus capabilities, even when the Z-distance from the specimen´s focal plane is much larger, as it frequently occurs in specimens with a strong topography. The user can also set focus points manually, to achieve superior results for difficult samples, leading to an improved reliability for the whole virtual slide acquisition process. In addition, a newly developed sharpness filter for the dotSlide camera results in improved contrast, with virtual slide images appearing highly-defined and even clearer than before.

Label Scan is a new feature that enables dotSlide to scan the slide´s label along with the overview image allowing users to get an impression of the complete slide, and not only of the area that contains the specimen. In addition, mistakes from typing in data manually can be avoided as the label is a secure proof of the identity of the slide.

The integrated, versatile Net Image Server (NIS) SQL expands the dotSlide product range family with a client server database and allows users to manage any kind of image in a simple and convenient way. This powerful tool enables scanned images to be automatically uploaded to the database making them readily available for immediate remote access and multiple keyword queries. Customised database fields, user defined database structure offer greater flexibility, and NIS SQL also supports multiple file repository systems to allow secure, easy networking between different scanning units within one database.

Source: Olympus Life and Material Science Europa GMBH

July 23, 2008

USB Webcam

pc-microscope.jpg

What could possibly be a better gift for your family than this? This USB Microscope, Webcam, Hub combo gadget is a must have! Want to take a closer look at the soda cap that has been sitting under your desk for the last three years? Here’s a way to do so.

The Microscope part of this gadget actually works without the USB, though when plugged into the USB port, you can view the specimen on your computer screen, and even add text and special effects to whatever scientific monstrosity you can view with this device. You’ll need Windows XP and 2 AA batteries to operate this toy. Just don’t go feeding it to your dog. It’s not a USB Dog Toy. And we doubt your dog is interested anyway. Get your own for $70. — Andrew Dobrow

July 22, 2008

Bioinformatics Pioneer Will Lead New Initiatives at Emory University

WEBWIRE – Monday, July 21, 2008

Joel H. Saltz, MD, PhD, a pioneer in the fields of high-performance computing and biomedical informatics, will join Emory University’s Woodruff Health Sciences Center in September as director of the Center for Comprehensive Informatics and as Emory Healthcare’s Chief Medical Information Officer. The announcement was made by Fred Sanfilippo, MD, PhD, Emory executive vice president for health affairs, CEO of the Woodruff Health Sciences Center and chairman of Emory Healthcare.

Saltz will help develop and lead new initiatives that are expected to fuel scientific discovery in health and medicine and to empower more precise and scientifically informed decision-making in patient care, says Sanfilippo.

Saltz currently serves as professor and chair of the Department of Biomedical Informatics and professor in the Department of Computer Science and Engineering at The Ohio State University (OSU), Davis Endowed Chair of Cancer at OSU, and a senior fellow of the Ohio Supercomputer Center. Prior to coming to OSU, Saltz was professor of pathology and informatics in the Department of Pathology at Johns Hopkins School of Medicine and professor in the Department of Computer Science at the University of Maryland.

With more than $4.7 million in National Institutes of Health funding and some $70 million in total active grant funding, Saltz has more than 325 publications and 70 invited presentations to his credit. He is trained both as a computer scientist and as a medical scientist. He received his MD and his PhD (computer science) degrees at Duke University. He completed a residency in clinical pathology at Johns Hopkins University and is a board-certified clinical pathologist.

As chief medical information officer for Emory Healthcare, Saltz will direct strategic planning and implementation of the comprehensive Emory Medical Information Enterprise. He will guide recruitment, research and resource allocation for informatics programs across academic departments. Additionally, he will lead the further development of Emory’s external partnerships in bioinformatics, including those with the Georgia Institute of Technology, Children’s Healthcare of Atlanta, Morehouse School of Medicine, the Atlanta Veterans Affairs Medical Center, the Georgia Research Alliance and the Georgia Cancer Coalition.

"Dr. Saltz will help us achieve our vision of transforming health and healing by applying computer science to the overarching challenges facing the biological and biomedical sciences" says Sanfilippo. "He will accelerate our already outstanding momentum in biomedical research as we continue to increase the quality of care we provide to our patients and their families. His addition to our faculty is a significant step forward toward our goal of being the 21st century model of an academic health sciences and health services center"

Among his many noteworthy achievements, Saltz has been a leader in the cancer Biomedical Informatics Grid (caBIG), an initiative of the National Cancer Institute Center for Biomedical Informatics and Information Technology. The initiative helps cancer researchers, clinicians and patients share relevant data and information, speed translation of new cancer diagnostics and therapies from the laboratory to the community and help fully realize the potential of predictive health. Saltz has spearheaded other groundbreaking biomedical information projects in cardiovascular medicine, clinical research and imaging. While at Johns Hopkins in 1996, he created prototypes for the first virtual microscope software.

The field of bioinformatics uses computer technology to analyze and interpret a wealth of biological data generated from fundamental research and translates that information into the knowledge necessary to develop medical innovations. Biomedical informatics will enhance established and emerging Emory programs in the neurosciences, predictive health, computational and life sciences, transplantation, global health, vaccines and inflammation, regenerative medicine, respiratory health, cardiovascular health, cancer and clinical trials.

July 21, 2008

Some pathology experts say staffing, funding constraints may be behind surge in testing errors

Medscape (7/19, Gandey) reported that a number of "[e]xperts say staffing and funding constraints are making it difficult for pathologists to do their jobs, and it is more likely that testing errors will occur." Meanwhile, pathologists in Canada came "under fire recently after a series of mistakes in the lab were made public." In Newfoundland, "nearly 400 breast cancer cases went undetected over an eight-year period," and approximately "100 of these women died after their test results were misread." Yet, the problem "should encourage oncologists to remain vigilant and verify results." Jared Schwartz, M.D., "president of the College of American Pathologists," suggested "that doctors adopt a more collaborative approach, and work more closely with one another." Noting that "pathology, like most areas of medicine, is an art as well as a science," Dr. Schwartz said, "At the end of the day, it is an opinion." But, "[o]ur goal is always to provide the most scientifically accurate diagnosis that we can," and even though "results can vary,...we have to work with that," he concluded.

Educational Sponsors

Your email address:


Powered by FeedBlitz

Feeds

  • http://www.wikio.com

Medicine 2.0


Search

  • Google

    WWW
    tissuepathology.typepad.com

StumbleUpon

Technorati

  • Add to Technorati Favorites

Zimbio

Photo Atlas

Twitter Updates

    follow me on Twitter

    July 2009

    Sun Mon Tue Wed Thu Fri Sat
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31  

    Google Analytics

    Site Meter